Cure Alzheimer's Fund Cure Alzheimer's Fund

Since our inception in 2004, our steadfast focus has been providing research grants to the worlds’ leading scientists researching Alzheimer’s disease. We are honored to work with scientists who are passionate in their pursuit to rid our world of this debilitating disease.

Many of the funded projects have resulted in significant breakthroughs in developing a better understanding of Alzheimer’s disease and getting closer to a cure.


Search

Title Researchers Date
Microbiome Consortium: Microbial Profiling of Human Brain and Gut Microbiomes in Alzheimer’s Disease Rudy Tanzi Nanda Kumar Navalpur Shanmugam 2026-02-18
Microbiome Consortium: Interaction of the Microbiome with Astrocytes and Amyloid Pathology Robert Vassar 2026-02-18
Microbiome Consortium: The Role of Gut Microbial Metabolism in Tau-Mediated Neurodegeneration David Holtzman 2026-02-18
Microbiome Consortium: Quantitative Strain-Level Resolution Characterization of the Microbiome in Alzheimer’s Will Resolve Apparently Contradictory Findings Among Studies and Provide Better Relationships with Metabolomic, Proteomic and Lipidomic Markers Rob Knight 2026-02-18
Microbiome Consortium: The Gut Microbiome as the Driver of the Senescence-Associated Secretory Phenotype in Alzheimer’s Disease and Its Role in Cognitive Decline John Haran Beth McCormick 2026-02-17
Microbiome Consortium: Temporal Relationships Between Gut Dysbiosis, Brain Amyloid Beta Metabolism and Microglia Cell Activation Following Antibiotic Treatment; Roles of Sex Hormones Sangram S. Sisodia 2026-02-17
Microbiome Consortium: Harnessing Diet-Microbe Interactions to Prevent Alzheimer’s Disease Pathogenesis Laura Cox 2026-02-17
A Muti-Modality Study on Lipid Molecular Basis of Obesity and Its Roles in Regulating Alzheimer’s Pathogenesis for Developing Potential Targeted Interventions Stephen T.C. Wong 2026-02-13
Advancing Late-Onset Alzheimer’s Disease Modeling Through Identification of Neurodegeneration Genes and Vulnerable Neuronal Subtypes Andrew S. Yoo 2026-02-13
TurboID-Based Characterization of Extracellular Vesicle-Mediated GABAergic Neuronal Dysfunction in Alzheimer’s Disease Tsuneya Ikezu 2026-02-13
Role of Checkpoint Molecules TIM-3 and LAG-3 in Microglial Regulation and Alzheimer’s Disease Pathology Vijay K. Kuchroo 2026-02-04
Detection, Classification, and Propagation of Tau Strains Marc Diamond 2026-01-30
Menopause and Related Midlife Risk Factors and Their Impact on Pathology and Cognition: The WHIMSYAD Study Rachel Buckley 2025-12-31
Expanding Deep South Inclusion in the UAB ADRC Neuropathology Core Brain Bank Kirsten Schoonover Rati Chkheidze 2025-12-31
Bridge Funding for a Younger Diverse Human Brain Bank to Investigate Early Alzheimer’s Disease Pathology Meaghan Morris Juan Troncoso Ling Li 2025-12-31
Restoring Brain Collection in New York City Through the Mount Sinai Neuropathology Brain Bank John Crary 2025-12-31
Expanding Postmortem Brain Resources for Alzheimer’s Disease in Diverse Populations Sabina Berretta Thomas Blanchard 2025-12-31
Digital Neuropathology Infrastructure for Precision Medicine in South Texas Hispanic Alzheimer’s Disease and Alzheimer’s Disease Related Dementias (AD/ADRD) Populations Sudha Seshadri 2025-12-31
Viral Infections and Alzheimer’s Disease Risk in Women Yu Chen Stephen Elledge 2025-12-31
G2T Research Models and Materials Taconic Biosciences 2025-12-31